Cytotoxic T cells engineered with the BOB1-specific TCR can recognize and kill myeloma cells expressing the BOB1 transcriptional coactivator intracellularly. The TCR is specific for BOB1 peptides presented by HLA class I molecules. Professional illustration by Patrick Lane, ScEYEnce Studios.